L. Ørskov

994 total citations
25 papers, 742 citations indexed

About

L. Ørskov is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, L. Ørskov has authored 25 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Physiology and 7 papers in Surgery. Recurrent topics in L. Ørskov's work include Diabetes Management and Research (9 papers), Diet and metabolism studies (8 papers) and Pancreatic function and diabetes (7 papers). L. Ørskov is often cited by papers focused on Diabetes Management and Research (9 papers), Diet and metabolism studies (8 papers) and Pancreatic function and diabetes (7 papers). L. Ørskov collaborates with scholars based in Denmark, United Kingdom and Japan. L. Ørskov's co-authors include Niels Møller, O. Schmitz, Ulla Kampmann, B. Nyholm, Britt Christensen, Claus Højbjerg Gravholt, Ole Schmitz, Jens J. Holst, Claus Bogh Juhl and Louise Wamberg and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

L. Ørskov

25 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Ørskov Denmark	15	370	252	207	141	108	25	742
Clarice Gravena Brazil	19	209 0.6×	288 1.1×	382 1.8×	125 0.9×	53 0.5×	28	816
M. Côté Canada	10	252 0.7×	119 0.5×	248 1.2×	112 0.8×	71 0.7×	15	780
Yohnosuke Shimomura Japan	17	273 0.7×	76 0.3×	160 0.8×	121 0.9×	39 0.4×	43	696
Yuko Akehi Japan	14	307 0.8×	189 0.8×	156 0.8×	156 1.1×	27 0.3×	37	688
M Feldpausch Germany	4	427 1.2×	193 0.8×	455 2.2×	110 0.8×	76 0.7×	5	1.1k
Yukako Kinoshita Japan	19	164 0.4×	190 0.8×	164 0.8×	155 1.1×	180 1.7×	51	860
Alessandra Calcagno Italy	13	308 0.8×	170 0.7×	458 2.2×	162 1.1×	48 0.4×	22	1.1k
Wenshan Lv China	10	252 0.7×	100 0.4×	194 0.9×	125 0.9×	73 0.7×	25	632
Hiroshi Kajinuma Japan	17	503 1.4×	363 1.4×	203 1.0×	315 2.2×	67 0.6×	42	1.0k
R Sendur Poland	14	94 0.3×	268 1.1×	140 0.7×	74 0.5×	32 0.3×	44	616

Countries citing papers authored by L. Ørskov

Since Specialization

Citations

This map shows the geographic impact of L. Ørskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Ørskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Ørskov more than expected).

Fields of papers citing papers by L. Ørskov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Ørskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Ørskov. The network helps show where L. Ørskov may publish in the future.

Co-authorship network of co-authors of L. Ørskov

This figure shows the co-authorship network connecting the top 25 collaborators of L. Ørskov. A scholar is included among the top collaborators of L. Ørskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Ørskov. L. Ørskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kampmann, Ulla, Leif Mosekilde, Claus Bogh Juhl, et al.. (2014). Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial. Metabolism. 63(9). 1115–1124. 116 indexed citations

Kampmann, Ulla, Leif Mosekilde, O. Schmitz, et al.. (2012). Lack of effects of high dose colecalciferol (D3) on insulin sensitivity and metabolic markers in type 2 diabetic patients: a double-blind, randomised, placebo-controlled trial. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations

Nielsen, Thomas S., Ulla Kampmann, Roni Nielsen, et al.. (2012). Reduced mRNA and Protein Expression of Perilipin A and G0/G1 Switch Gene 2 (G0S2) in Human Adipose Tissue in Poorly Controlled Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1348–E1352. 22 indexed citations

Kampmann, Ulla, A. Mengel, Ole Schmitz, et al.. (2011). Insulin dose–response studies in severely insulin‐resistant type 2 diabetes—evidence for effectiveness of very high insulin doses. Diabetes Obesity and Metabolism. 13(6). 511–516. 14 indexed citations

Kampmann, Ulla, Britt Christensen, Thomas S. Nielsen, et al.. (2011). GLUT4 and UBC9 Protein Expression Is Reduced in Muscle from Type 2 Diabetic Patients with Severe Insulin Resistance. PLoS ONE. 6(11). e27854–e27854. 77 indexed citations

Djurhuus, Christian, Troels Krarup Hansen, Claus Højbjerg Gravholt, et al.. (2002). Circulating Levels of Ghrelin and GLP-1 are Inversely Related During Glucose Ingestion. Hormone and Metabolic Research. 34(7). 411–413. 36 indexed citations

Rasmussen, Birthe M., L. Ørskov, Ole Schmitz, & Kjeld Hermansen. (2001). Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects. Metabolism. 50(4). 451–457. 12 indexed citations

Ørskov, L., O. Schmitz, J. F. Bak, et al.. (2001). Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects. Scandinavian Journal of Clinical and Laboratory Investigation. 61(5). 371–381. 3 indexed citations

Nyholm, B., Birgitte Brock, L. Ørskov, & Ole Schmitz. (2001). Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus. Expert Opinion on Investigational Drugs. 10(9). 1641–1652. 12 indexed citations

10.

Poulsen, Per Løgstrup, L. Ørskov, Thorbjørn Grøfte, et al.. (2000). Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man. Metabolism. 49(12). 1598–1603. 3 indexed citations

11.

Nyholm, B., L. Ørskov, Claus Højbjerg Gravholt, et al.. (1999). The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism. 48(7). 935–941. 85 indexed citations

12.

Ørskov, L., et al.. (1999). Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects. Diabetic Medicine. 16(10). 861–866. 20 indexed citations

13.

Schmitz, O., et al.. (1997). Effects of hyperinsulinaemia and hypoglycaemia on circulating leptin levels in healthy lean males.. PubMed. 23(1). 80–3. 24 indexed citations

14.

Ørskov, L., Niels Møller, J. F. Bak, Niels Pörksen, & O. Schmitz. (1996). Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus. Metabolism. 45(2). 211–217. 20 indexed citations

15.

Møller, Niels, Jens Otto Lunde Jørgensen, Jens Møller, et al.. (1995). Metabolic effects of growth hormone in humans. Metabolism. 44(10 Suppl 4). 33–36. 43 indexed citations

16.

Schmitz, O., L. Ørskov, Sten Lund, et al.. (1993). Glucose Metabolism in Chronic Renal Failure with Reference to GH Treatment of Uremic Children. Journal of Pediatric Endocrinology and Metabolism. 6(1). 53–9. 7 indexed citations

17.

Møller, Niels, Jens Otto Lunde Jørgensen, J. Møller, et al.. (1990). Lack of effects of hyperglycemia on the disposal of 3-hydroxybutyrate in insulin-dependent diabetic patients. European Journal of Endocrinology. 123(6). 629–632. 2 indexed citations

18.

Seefeldt, Torben, L. Ørskov, A. Mengel, et al.. (1990). Lack of Effects of Angiotensinconverting Enzyme (ACE)‐inhibitors on Glucose Metabolism in Type 1 Diabetes. Diabetic Medicine. 7(8). 700–704. 27 indexed citations

19.

Schmitz, O., et al.. (1988). Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.. PubMed. 30(1). 27–34. 5 indexed citations

20.

Ørskov, L., Jannik E. Jakobsen, E. Dupont, Bent de Fine Olivarius, & N. J. Christensen. (1987). Autonomic function in parkinsonian patients relates to duration of disease. Neurology. 37(7). 1173–1173. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact